{"product_id":"isothermal-nucleic-acid-amplification-technology-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eIsothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003e\nMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2028, exhibiting a growth rate (CAGR) of 12.3% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eThe isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. It is majorly utilized for RNA, DNA, cells, proteins, small molecules, and ions to ensure the rapid, sensitive and accurate diagnosis of genetic, inherited, and infectious diseases. It generates amplicons that are employed in producing versatile nucleic acid nanomaterials. Besides this, it assists in detecting various infectious diseases, such as (HIV), tuberculosis, influenza, hepatitis A and B, chlamydia, and gonorrhea (CT\/NG). As a result, INAAT is gaining immense traction across the globe.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Isothermal Nucleic Acid Amplification Technology Market Trends:\u003cbr\u003e\nThe ongoing development in INAAT for detecting coronavirus disease (COVID-19) represents one of the key factors positively influencing the market. In line with this, the increasing geriatric population globally and the rising prevalence of cancer and other chronic medical disorders, along with the escalating demand for efficient diagnosis and treatment alternatives, are contributing to the market growth. Apart from this, the adoption of loop-mediated isothermal amplification (LAMP) tests to amplify DNA and RNA and the identification of genetically modified organisms (GMOs) is catalyzing the demand for INAAT. Furthermore, the development of strand displacement amplification (SDA), single primer isothermal amplification (SPIA), and recombinase polymerase amplification (RPA) are acting as another growth-inducing factor. Moreover, increasing investments in research and development (R\u0026amp;D) activities by leading market players are projected to drive the market.\u003c\/p\u003e \n\n\u003cp\u003eKey Market Segmentation:\u003cbr\u003e\nIMARC Group provides an analysis of the key trends in each sub-segment of the global isothermal nucleic acid amplification technology market report, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on product, technology, application, and end-user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eInstruments\u003cbr\u003e\nReagents\u003c\/p\u003e\n\n\u003cp\u003eReagents hold the majority of the global isothermal nucleic acid amplification technology market share due to their increasing use in therapeutics.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Technology:\u003c\/p\u003e\n\n\u003cp\u003eHelicase-Dependent Amplification (HDA)\u003cbr\u003e\nNicking Enzyme Amplification Reaction (NEAR)\u003cbr\u003e\nLoop-Mediated Isothermal Amplification (LAMP)\u003cbr\u003e\nStrand Displacement Amplification (SDA)\u003cbr\u003e\nNucleic Acid Sequence-Based Amplification (NASBA)\u003cbr\u003e\nTranscription Mediated Amplification (TMA)\u003cbr\u003e\nSingle Primer Isothermal Amplification (SPIA)\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eTMA accounts for the majority of the total market share as it allows a clinical laboratory to perform nucleic acid test (NAT) assays for blood screening with fewer steps and less processing time.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eInfectious Disease Diagnosis\u003cbr\u003e\nHepatitis\u003cbr\u003e\nCT\/NG\u003cbr\u003e\nHIV\u003cbr\u003e\nInfluenza\u003cbr\u003e\nOthers\u003cbr\u003e\nBlood Screening\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eInfectious disease diagnosis currently dominates the market due to the rising prevalence of infectious diseases across the globe.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End-User:\u003c\/p\u003e\n\n\u003cp\u003eHospitals\u003cbr\u003e\nDiagnostic Laboratories\u003cbr\u003e\nResearch Laboratories\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eHospitals presently dominate the market due to the increasing number of hospitals and significant development in the healthcare industry.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eNorth America exhibits a clear dominance in the market due to the shifting consumer preference for INAAT testing over traditional diagnostic procedures.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Eiken Chemical Co. Ltd., Hologic Inc., Meridian Bioscience Inc., OptiGene Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, and Ustar Biotechnologies Ltd.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report:\u003c\/p\u003e\n\n\u003cp\u003eHow has the global isothermal nucleic acid amplification technology market performed so far and how will it perform in the coming years?\u003cbr\u003e\nWhat are the key regional markets?\u003cbr\u003e\nWhat has been the impact of COVID-19 on the global isothermal nucleic acid amplification technology market?\u003cbr\u003e\nWhat is the breakup of the market based on the product?\u003cbr\u003e\nWhat is the breakup of the market based on the technology?\u003cbr\u003e\nWhat is the breakup of the market based on the application?\u003cbr\u003e\nWhat is the breakup of the market based on the end-user?\u003cbr\u003e\nWhat are the various stages in the value chain of the industry?\u003cbr\u003e\nWhat are the key driving factors and challenges in the industry?\u003cbr\u003e\nWhat is the structure of the global isothermal nucleic acid amplification technology market and who are the key players?\u003cbr\u003e\nWhat is the degree of competition in the industry?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 142 Pages \/ MCW16237364","offer_id":47652447945010,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/isothermal-nucleic-acid-amplification-technology-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}